Encoded Therapeutics Inc.

Ever wondered what it takes to make a #GeneTherapy? Join us on a virtual lab tour at Encoded's headquarters in South Francisco, and meet a few of our talented scientists ready to explain what goes on behind the scenes as we work to develop potential #GeneTherapies. https://bit.ly/3yONIB9

On Dravet Syndrome Awareness Day, discover the touching stories of three families who share what they love most about their incredible children living with Dravet Syndrome and the daily challenges they face. Watch now and see why "Little Moments Matter" from Dravet Syndrome UK: https://ow.ly/2StS50SoyE8 #DravetSyndrome

Join us on International Dravet Syndrome Awareness Day, and every day, in honoring the resilient #DravetSyndrome community. We celebrate the strength, courage, and unwavering dedication of families living with Dravet as well as the whole community that, together, is driving research and innovation towards better lives for everyone affected. Learn more and be inspired by powerful stories from Dravet families: https://ow.ly/YByU50SnEq0. We are proud to be part of this dynamic community as we progress in developing #ETX101, a gene regulation therapy for SCN1A+ Dravet. #DravetAwarenessDay #DravetAwarenessMonth #Dravet #POLARIS Dravet Syndrome Foundation

In a new Global Genes #RARECast titled, "Differentiating Gene Therapies through Regulatory Elements," Encoded's Chief Medical Officer Salvador Rico, MD, PhD discusses our investigational gene regulation therapy for Dravet syndrome and how our technology optimizes gene therapies through vector engineering to precisely target gene expression to specific cell types. Listen now: https://ow.ly/nccw50SbykQ #DravetSyndrome #Dravet #GeneTherapy #GeneTherapies #GlobalGenes

In a CGTLive interview earlier this year, Salvador Rico, MD, PhD, Chief Medical Officer of Encoded, discussed how the POLARIS program will inform clinical development and assessment of our investigational gene therapy for Dravet syndrome. We're excited that since this interview, all three of the POLARIS trials (ENDEAVOR, WAYFINDER, and EXPEDITION) have received regulatory approval and are currently enrolling patients. Watch now: lnkd.in/ez9Q3mfS #DravetSyndrome #Dravet #GeneTherapy #GeneTherapies #ClinicalTrials #ETX101

Today, on #ClinicalTrialsDay, and every day, we honor and thank everyone involved in our clinical trials, from all the dedicated professionals to the patient participants, for their invaluable contributions to advancing gene therapies for pediatric CNS disorders. Learn more: https://ow.ly/ymqa50RNZrL #ClinicalTrials #CTD2024 #GeneTherapy #GeneTherapies #ETX101 #Dravetsyndrome

Join Chao Tai, Encoded Senior Scientist, as he presents "Identification of Potent and Selective AAV-miRNA Candidates to Knockdown Non-Monogenic Neurological Targets SCN9A (Pain) and MAPT (Tauopathies)" at the American Society of Gene & Cell Therapy's 27th Annual Meeting. Attend his poster presentation (# 1601) on Friday, May 10, at 5:30 p.m. Read the abstract at: https://ow.ly/9U6I50RBTUx. The presentation is one of five in which we're showcasing updates on the progress of our preclinical programs at #ASGCT2024. See our schedule at https://ow.ly/G6VQ50RBTUw #ASGCT2024 #GeneTherapy #GeneTherapies

Join Sirika Pillay, PhD, Encoded Director, Molecular & Cellular Pharmacology - Preclinical, as she presents "A Vectorized miRNA-based Approach to Unsilence UBE3A in Angelman Syndrome" at the American Society of Gene & Cell Therapy's 27th Annual Meeting. Attend her poster presentation (# 1125) on Thursday, May 9, at 5:30 p.m. Read the abstract at: https://ow.ly/IsF350RAhaO. The presentation is one of five in which we're showcasing updates on the progress of our preclinical programs at #ASGCT2024. See our schedule at https://ow.ly/2YV850RAhaP #ASGCT2024 #GeneTherapy #GeneTherapies #AngelmanSyndrome

Join Stephanie Tagliatela, Chief Scientific Officer, as she presents “Dose Scaling From Preclinical Models to First-In-Human (FIH) for Local CNS AAV Gene Therapies” at the American Society of Gene & Cell Therapy's 27th Annual Meeting. Attend her presentation at the scientific symposium, “Searching for Goldilocks – Scaling for AAV Clinical Dose Prediction” on Thursday, May 9, at 8 a.m. Read the program details at: https://ow.ly/gPQn50RA1uI. The presentation is one of five in which we're showcasing updates on the progress of our preclinical programs at #ASGCT2024. See our schedule at https://ow.ly/IS8Z50RA1uH #ASGCT2024 #GeneTherapy #GeneTherapies #DravetSyndrome #Dravet #ETX101

Join Rangoli Aeran, Encoded Senior Scientist, as she presents "Advancing Gene Therapy for STXBP1-related Disorders Through Targeted Vector Engineering: Efficacy and Safety Results in Mice and Non-Human Primates" at the American Society of Gene & Cell Therapy's 27th annual meeting. Attend her poster presentation (# 508) on Wednesday, May 8, at 5:30 p.m. Read the abstract at: https://ow.ly/XHsg50RzHuE. The presentation is one of five in which we're showcasing updates on the progress of our preclinical programs at #ASGCT2024. See our schedule at https://ow.ly/O40s50RzHuF #ASGCT2024 #GeneTherapy #GeneTherapies